Pharmacologically active pyridine derivatives and processes for the
申请人:Novartis Corporation
公开号:US05728708A1
公开(公告)日:1998-03-17
N-phenyl-2-pyrimidineamine derivatives of formula I ##STR1## wherein the substituents are as defined in claim 1 and the derivatives of formula I can be used, for example, in the treatment of tumour diseases.
PHARMACOLOGICALLY ACTIVE PYRIDINE DERIVATIVES AND PROCESSES FOR THE PREPARATION THEREOF
申请人:Novartis AG
公开号:EP0672041B1
公开(公告)日:2001-11-14
PYRIMIDINE DERIVATIVES
申请人:GPC Biotech AG
公开号:EP1786781A2
公开(公告)日:2007-05-23
US5728708A
申请人:——
公开号:US5728708A
公开(公告)日:1998-03-17
[EN] PHARMACOLOGICALLY ACTIVE PYRIDINE DERIVATIVES AND PROCESSES FOR THE PREPARATION THEREOF<br/>[FR] DERIVES PYRIDINE PHARMACOLOGIQUEMENT ACTIFS AINSI QUE LEURS PROCEDES DE PREPARATION
申请人:CIBA-GEIGY AG
公开号:WO1995009853A1
公开(公告)日:1995-04-13
(EN) N-phenyl-2-pyrimidineamine derivatives of formula (I) wherein the substituents are as defined in claim 1 are described. Those compounds can be used, for example, in the treatment of tumour diseases.(FR) L'invention se rapporte à des dérivés de N-phényl-2-pyrimidineamine de formule (I) dans laquelle les substituants sont tels que définis dans la revendication 1. On peut utiliser ces composés, par exemple, dans le traitement des affections tumorales.